142nd APHA Annual Meeting and Exposition

Annual Meeting Recordings are now available for purchase

310129
Use of mini-grants to disseminate evidence-based interventions for cancer prevention and control

142nd APHA Annual Meeting and Exposition (November 15 - November 19, 2014): http://www.apha.org/events-and-meetings/annual
Tuesday, November 18, 2014 : 4:30 PM - 4:50 PM

Marcia Ory, PhD, MPH , Health Promotion and Community Health Sciences, Texas A&M HSC School of Rural Public Health, College Station, TX
Debra Kellstedt, MPH , School of Public Health, Texas A&M Health Science Center, College Station, TX
Michelle Carvalho, MPH , Rollins School of Public Health, Emory University, Atlanta, GA
Daniela B. Friedman, MSc, PhD , Arnold School of Public Health, University of South Carolina, Columbia, SC
James L. McCracken, MA , Cancer Prevention and Control Program, University of South Carolina, Columbia, SC
Maria E. Fernandez, PhD , Health Promotion and Behavioral Sciences, University of Texas Health Science Center at Houston, School of Public Health, Houston, TX
Glenna Dawson, MPH , School of Public Health, Center for Health Promotion and Prevention Research, University of Texas Health Science Center at Houston, Houston, TX
Michelle Kegler, DrPH , Department of Behavioral Science and Health Education, Rollins School of Public Health, Emory University, Atlanta, GA
Introduction:

Mini-grants are an increasingly utilized tool to engage communities in evidence-based practices for promoting public health. Common strategies for disseminating evidence-based interventions (EBI) include websites, registries, implementation manuals, webinars, trainings, and other forms of technical assistance. The purpose of this project was to describe the use of mini-grants to promote EBIs for cancer prevention and control.

Methods:

Four NIH/CDC-funded Cancer Prevention and Control Research Network (CPCRN) sites are at various stages of engagement in a mini-grant process. The sites came together to describe their mini-grant strategies using the following categories: description and source of EBI, specific EBI or policy/environment changes, funding levels, review and selection criteria, and timeframe. They further described the grantees by site in the following categories: number of grants awarded, types of organizations funded, and selected accomplishments.

Results:

The majority of mini-grants awarded covered topics such as physical activity and nutrition. The amount of resources offered ranged from $1,000 to $10,000. Most grants went to community-based organizations. This mini-grant opportunity was characterized by its emphasis on technical assistance for evidence-based programming. All projects had some evaluation component, although there was great variability in the scope of the evaluations.

Conclusion:

Working in partnership with other organizations helped to facilitate the implementation and evaluation of evidence-based strategies for cancer prevention and control. Standardized evaluation tools may help communities better implement EBIs. The mini-grant processes described serve as a model for the promotion of public health topics in other domains.

Learning Areas:

Administer health education strategies, interventions and programs
Chronic disease management and prevention
Implementation of health education strategies, interventions and programs
Planning of health education strategies, interventions, and programs

Learning Objectives:
Describe the use of mini-grants to promote EBIs for cancer prevention and control

Keyword(s): Community-Based Partnership & Collaboration, Cancer Prevention and Screening

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am a project director at the Texas A&M Health Science Center School of Public Health--a Cancer Prevention Control Research Network site, and I administered the mini-grant program at our site.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.